Covered recipient · General Payments record
MARK PAAUW
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2024
$2,119.67
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,253.68 | 13 |
| Travel and Lodging | $865.99 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alcon Laboratories Inc | $1,337.82 | 6 |
| ABBVIE INC. | $305.14 | 5 |
| RxSight Inc | $240.30 | 2 |
| Sight Sciences, Inc. | $124.35 | 1 |
| GLAUKOS CORPORATION | $90.00 | 1 |
| Harrow Eye, LLC | $22.06 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $2,119.67 | 16 |
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.57 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105166448 | CMS |
| ABBVIE INC. | $107.53 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105166450 | CMS |
| ABBVIE INC. | $20.61 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105166452 | CMS |
| ABBVIE INC. | $18.18 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105166454 | CMS |
| ABBVIE INC. | $134.25 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105166456 | CMS |
| Alcon Vision LLC | $144.15 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110694273 | CMS |
| Alcon Vision LLC | $19.95 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110694271 | CMS |
| Alcon Vision LLC | $204.78 | 11/01/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1110528866 | CMS |
| Alcon Vision LLC | $236.81 | 11/01/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1110528868 | CMS |
| Alcon Vision LLC | $424.40 | 11/01/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1110528870 | CMS |
| Alcon Vision LLC | $307.73 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110694275 | CMS |
| Glaukos Corporation | $90.00 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151976948 | CMS |
| Harrow Eye, LLC | $22.06 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145611321 | CMS |
| RxSight Inc | $100.00 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144224149 | CMS |
| RxSight Inc | $140.30 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144224154 | CMS |
| Sight Sciences, Inc. | $124.35 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151928567 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.